We therefore used the interferon receptor-deficient transgenic knockout (Ifnar1−/−) A129 mice, which are susceptible to ZIKV infection and which have been shown to be amenable to vaccine evaluation studies (31). This evidence concerns the gene IFNAR2 and Zika virus infectious disease.